Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines

Andreidesz, Kitti and Szabó, Alíz and Kovács, Dominika and Kőszegi, Balázs and Bagone Vantus, Viola and Vámos, Eszter and Isbera, Mostafa and Kalai, Tamás and Bognár, Zita and Kovács, Krisztina and Gallyas, Ferenc (2021) Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22 (16). No. 9016. ISSN 1422-0067

Preview

Text ijms-22-09016-v2-2.pdf - Published Version Available under License Creative Commons Attribution. Download (34MB) | Preview

Abstract

Mitochondria have emerged as a prospective target to overcome drug resistance that limits triple-negative breast cancer therapy. A novel mitochondria-targeted compound, HO-5114, demonstrated higher cytotoxicity against human breast cancer lines than its component-derivative, Mito-CP. In this study, we examined HO-51140 s anti-neoplastic properties and its effects on mitochondrial functions in MCF7 and MDA-MB-231 human breast cancer cell lines. At a 10 µM concentration and within 24 h, the drug markedly reduced viability and elevated apoptosis in both cell lines. After seven days of exposure, even at a 75 nM concentration, HO-5114 significantly reduced invasive growth and colony formation. A 4 h treatment with 2.5 µM HO-5114 caused a massive loss of mitochondrial membrane potential, a decrease in basal and maximal respiration, and mitochondrial and glycolytic ATP production. However, reactive oxygen species production was only moderately elevated by HO-5114, indicating that oxidative stress did not significantly contribute to the drug’s anti-neoplastic effect. These data indicate that HO-5114 may have potential for use in the therapy of triple-negative breast cancer; however, the in vivo toxicity and anti-neoplastic effectiveness of the drug must be determined to confirm its potential.

Actions (login required)

Edit Item